You can buy or sell Harrow Health and other stocks, options, ETFs, and crypto commission-free!
Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. Read More The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN. The listed name for HROW is Harrow Health, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 9, After Hours